C

Clearside Biomedical
D

CLSD

0.87300
USD
0.03
(2.95%)
مغلق
حجم التداول
147
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
67,464,817
أصول ذات صلة
C
CRSP
0.520
(1.38%)
38.220 USD
C
CRVS
0.12000
(3.43%)
3.62000 USD
E
EDIT
0.01500
(0.93%)
1.63000 USD
N
NTLA
0.20000
(2.32%)
8.83000 USD
R
RGNX
0.560
(5.70%)
10.390 USD
S
SGMO
-0.01210
(-1.63%)
0.72800 USD
V
VCEL
1.025
(2.70%)
38.935 USD
المزيد
الأخبار المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.